International Breast Cancer Study Group (IBCSG) trial 23-01
Continuing follow-up data from the IBCSG trial 23-01 reported at the recent San Antonio Breast Cancer Symposium indicates no differences between disease-free or overall survival in patients who did not receive axillary node dissection vs. those who did in the setting of minimal sentinal node disease. The study looked at 931 women randomized from 27 Continue Reading


